Laurion Capital Management LP Kura Oncology, Inc. Transaction History

Laurion Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$10.71 - $18.33 $722,207 - $1.24 Million	-67,433 Reduced 57.42%	50,000 $917,000
Q1 2022 May 16, 2022	BUY	$11.78 - $16.98 $794,360 - $1.15 Million	67,433 Added 134.87%	117,433 $1.89 Million
Q3 2021 Nov 15, 2021	BUY	$15.42 - $21.72 $771,000 - $1.09 Million	50,000 New	50,000 $937,000
Q4 2020 Feb 12, 2021	SELL	$29.0 - $41.62 $301,600 - $432,848	-10,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$16.3 - $30.64 $169,520 - $318,656	10,400 New	10,400 $319,000
Q3 2019 Nov 13, 2019	SELL	$14.75 - $20.87 $368,750 - $521,750	-25,000 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$14.71 - $19.79 $367,750 - $494,750	25,000 New	25,000 $492,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $603M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.